ALLERGIC RHINOCONJUNCTIVITIS
Clinical trials for ALLERGIC RHINOCONJUNCTIVITIS explained in plain language.
Never miss a new study
Get alerted when new ALLERGIC RHINOCONJUNCTIVITIS trials appear
Sign up with your email to follow new studies for ALLERGIC RHINOCONJUNCTIVITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy may offer lasting hay fever relief
Symptom relief CompletedThis study looked at whether taking a grass pollen tablet (SLIT) together with the drug dupilumab for 2 years can help adults with moderate to severe hay fever tolerate grass pollen better, even after stopping treatment. About 199 participants were involved. The main goal was to …
Matched conditions: ALLERGIC RHINOCONJUNCTIVITIS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New allergy pill shows promise in ragweed season trial
Symptom relief CompletedThis study tested a new drug called BLU-808 in 21 adults with ragweed allergies. The goal was to see if it is safe and helps reduce sneezing, runny nose, and itchy eyes caused by ragweed pollen. Participants were exposed to ragweed in a special chamber to measure the drug's effec…
Matched conditions: ALLERGIC RHINOCONJUNCTIVITIS
Phase: PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New birch allergy treatment shows promise for kids in major trial
Symptom relief CompletedThis study tested a medication called STALORAL Birch 300 IR in 553 children aged 5 to 17 with birch pollen allergies. The goal was to see if it safely reduces symptoms like sneezing, runny nose, and itchy eyes during pollen season. Participants received the treatment or a placebo…
Matched conditions: ALLERGIC RHINOCONJUNCTIVITIS
Phase: PHASE3 • Sponsor: Stallergenes Greer • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC